Solid Biosciences Inc. Logo

Solid Biosciences Inc.

Advancing gene therapies and technologies for rare neuromuscular and cardiac diseases.

SLDB | US

Overview

Corporate Details

ISIN(s):
US83422E2046
LEI:
Country:
United States of America
Address:
500 RUTHERFORD AVENUE, 2129 CHARLESTOWN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Solid Biosciences is a precision genetic medicine company dedicated to advancing a diverse portfolio of gene therapy candidates. The company focuses on treating rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich’s ataxia, catecholaminergic polymorphic ventricular tachycardia (CPVT), and various cardiomyopathies. In addition to its therapeutic pipeline, Solid Biosciences develops innovative enabling technologies, such as libraries of genetic regulators, to improve gene therapy delivery across the industry. Founded by individuals directly impacted by Duchenne, the company maintains a patient-focused mission to improve the lives of people living with devastating rare genetic diseases through scientific and technological expertise.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Solid Biosciences Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Solid Biosciences Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Solid Biosciences Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Perseus Proteomics Inc. Logo
Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.
Japan
4882
Personalis, Inc. Logo
Cancer genomics & liquid biopsy for early recurrence detection & guiding precision therapies.
United States of America
PSNL
Perspective Therapeutics, Inc. Logo
Developing targeted alpha radiotherapies using lead-212 to image and treat solid tumors.
United States of America
CATX
PharmAbcine Inc. Logo
Develops antibody therapies for cancer, eye diseases, and vascular-related disorders.
South Korea
208340
Pharma Foods International Co., Ltd. Logo
Researches and sells functional ingredients and direct-to-consumer health & beauty products.
Japan
2929
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain
PHM
Pharmanutra Logo
Researches and markets nutritional supplements & medical devices for all ages.
Italy
PHN
PHARMARESEARCH BIO Co., Ltd. Logo
A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.
South Korea
217950
PharmaResearch Co., Ltd. Logo
Develops regenerative medicine, devices & cosmetics using marine biotechnology.
South Korea
214450
PharmaSGP Holding SE Logo
Develops and markets leading natural OTC drugs for chronic conditions in the European market.
Germany
PSG

Talk to a Data Expert

Have a question? We'll get back to you promptly.